We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Cracked Vials Lead to Suspension of Dosing in Anthera Lupus Trial
Cracked Vials Lead to Suspension of Dosing in Anthera Lupus Trial
November 23, 2010
Cracked vials may set back Anthera Pharmaceuticals’ development plans for its lupus candidate, A-623.